These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 10221182)

  • 1. [Discovery of cell cycle inhibitors and their application to molecular biology].
    Yoshida M
    Jpn J Antibiot; 1999 Feb; 52(2):172-3. PubMed ID: 10221182
    [No Abstract]   [Full Text] [Related]  

  • 2. [Leptomycin: a specific inhibitor of protein nuclear export].
    Yoshida M; Kudo N; Horinouchi S
    Tanpakushitsu Kakusan Koso; 1999 Jul; 44(9):1379-88. PubMed ID: 10412289
    [No Abstract]   [Full Text] [Related]  

  • 3. Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export.
    Yoshida M; Horinouchi S
    Ann N Y Acad Sci; 1999; 886():23-36. PubMed ID: 10667200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trichostatins and leptomycins, new cell cycle inhibitors specific for G1 and G2 phases].
    Yoshida M; Beppu T
    Tanpakushitsu Kakusan Koso; 1989 Jul; 34(9):1069-81. PubMed ID: 2678278
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular targets of cell cycle inhibitors and their mode of action].
    Yoshida M
    Tanpakushitsu Kakusan Koso; 1996 Sep; 41(12 Suppl):1751-60. PubMed ID: 8890633
    [No Abstract]   [Full Text] [Related]  

  • 6. [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A].
    Yoshida M
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1788-9. PubMed ID: 18051427
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of serine palmitoyl-transferase activity by lipoxamycin.
    Mandala SM; Frommer BR; Thornton RA; Kurtz MB; Young NM; Cabello MA; Genilloud O; Liesch JM; Smith JL; Horn WS
    J Antibiot (Tokyo); 1994 Mar; 47(3):376-9. PubMed ID: 8175492
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells.
    Yoshida M; Hoshikawa Y; Koseki K; Mori K; Beppu T
    J Antibiot (Tokyo); 1990 Sep; 43(9):1101-6. PubMed ID: 2211374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of colchicine-SAHA hybrids as a new class of antitumor agents.
    Zhang X; Zhang J; Tong L; Luo Y; Su M; Zang Y; Li J; Lu W; Chen Y
    Bioorg Med Chem; 2013 Jun; 21(11):3240-4. PubMed ID: 23602523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of histone deacetylase inhibitors on p53 target gene expression, cell cycle and apoptosis in MCF-7 breast cancer cells.
    Knutson AK; Welsh J; Taylor T; Roy S; Wang WL; Tenniswood M
    Oncol Rep; 2012 Mar; 27(3):849-53. PubMed ID: 22159450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors.
    Angibaud P; Arts J; Van Emelen K; Poncelet V; Pilatte I; Roux B; Van Brandt S; Verdonck M; De Winter H; Ten Holte P; Marien A; Floren W; Janssens B; Van Dun J; Aerts A; Van Gompel J; Gaurrand S; Queguiner L; Argoullon JM; Van Hijfte L; Freyne E; Janicot M
    Eur J Med Chem; 2005 Jun; 40(6):597-606. PubMed ID: 15922843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.
    Marchion DC; Bicaku E; Daud AI; Richon V; Sullivan DM; Munster PN
    J Cell Biochem; 2004 May; 92(2):223-37. PubMed ID: 15108350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
    Mai A; Rotili D; Massa S; Brosch G; Simonetti G; Passariello C; Palamara AT
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1221-5. PubMed ID: 17196388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors.
    Bouchain G; Leit S; Frechette S; Khalil EA; Lavoie R; Moradei O; Woo SH; Fournel M; Yan PT; Kalita A; Trachy-Bourget MC; Beaulieu C; Li Z; Robert MF; MacLeod AR; Besterman JM; Delorme D
    J Med Chem; 2003 Feb; 46(5):820-30. PubMed ID: 12593661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines.
    Kisseberth WC; Murahari S; London CA; Kulp SK; Chen CS
    Am J Vet Res; 2008 Jul; 69(7):938-45. PubMed ID: 18593248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells.
    Wu Y; Guo SW
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):198-203. PubMed ID: 17376583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line.
    Galimberti S; Canestraro M; Maffei R; Marasca R; Guerrini F; Piaggi S; Ciabatti E; Petrini M
    Leukemia; 2009 Oct; 23(10):1935-8. PubMed ID: 19626048
    [No Abstract]   [Full Text] [Related]  

  • 19. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
    Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
    Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells.
    Greenberg VL; Williams JM; Cogswell JP; Mendenhall M; Zimmer SG
    Thyroid; 2001 Apr; 11(4):315-25. PubMed ID: 11349829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.